Thomas Wood - REMSleep Holdings CEO, Founder
| RMSL Stock | USD 0.01 0.0002 1.79% |
Insider
Thomas Wood is CEO, Founder of REMSleep Holdings
| Age | 77 |
| Phone | 813 367 3855 |
| Web | https://www.remsleeptech.com |
Thomas Wood Latest Insider Activity
Tracking and analyzing the buying and selling activities of Thomas Wood against REMSleep Holdings pink sheet is an integral part of due diligence when investing in REMSleep Holdings. Thomas Wood insider activity provides valuable insight into whether REMSleep Holdings is net buyers or sellers over its current business cycle. Note, REMSleep Holdings insiders must abide by specific rules, including filing SEC forms every time they buy or sell REMSleep Holdings'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Thomas Wood over two months ago Discretionary transaction by Thomas Wood of tradable shares of National Energy subject to Rule 16b-3 |
REMSleep Holdings Management Efficiency
The company has return on total asset (ROA) of (0.1839) % which means that it has lost $0.1839 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5467) %, meaning that it created substantial loss on money invested by shareholders. REMSleep Holdings' management efficiency ratios could be used to measure how well REMSleep Holdings manages its routine affairs as well as how well it operates its assets and liabilities.REMSleep Holdings currently holds 512.03 K in liabilities with Debt to Equity (D/E) ratio of 0.15, which may suggest the company is not taking enough advantage from borrowing. REMSleep Holdings has a current ratio of 7.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist REMSleep Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, REMSleep Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like REMSleep Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for REMSleep to invest in growth at high rates of return. When we think about REMSleep Holdings' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Sandra Eayrs | Nuwellis | N/A | |
| Robert LLB | Viemed Healthcare | 50 | |
| Alan Connaughton | LENSAR Inc | 53 | |
| William MD | Viemed Healthcare | 67 | |
| Elaine Leavenworth | Abbott Laboratories | 65 | |
| Trae Fitzgerald | Viemed Healthcare | 37 | |
| Christopher Scoggins | Abbott Laboratories | 54 | |
| Louis Morrone | Abbott Laboratories | 44 | |
| Alejandro Wellisch | Abbott Laboratories | 49 | |
| John Ginascol | Abbott Laboratories | 62 | |
| William MD | Nuwellis | N/A | |
| Richard Yazbeck | Lucid Diagnostics | N/A | |
| Michael CRT | Viemed Healthcare | 48 | |
| Michael Pederson | Abbott Laboratories | 59 | |
| Michael Freeman | Viemed Healthcare | N/A | |
| Scott Miller | 908 Devices | N/A | |
| Bradley JD | Axogen Inc | 54 | |
| Kendra Wong | LENSAR Inc | 45 | |
| James Young | Abbott Laboratories | N/A | |
| Mary Moreland | Abbott Laboratories | 59 | |
| Brian MD | Lucid Diagnostics | 60 | |
Management Performance
| Return On Equity | -0.55 | |||
| Return On Asset | -0.18 |
REMSleep Holdings Management Team
Elected by the shareholders, the REMSleep Holdings' board of directors comprises two types of representatives: REMSleep Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of REMSleep. The board's role is to monitor REMSleep Holdings' management team and ensure that shareholders' interests are well served. REMSleep Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, REMSleep Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jonathan Lane, Chief Engineer and Director | ||
| Russell Bird, CEO and President and Director | ||
| Thomas Wood, CEO, Founder |
REMSleep Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is REMSleep Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.55 | |||
| Return On Asset | -0.18 | |||
| Operating Margin | (3.58) % | |||
| Current Valuation | 17.17 M | |||
| Shares Outstanding | 1.46 B | |||
| Shares Owned By Insiders | 3.63 % | |||
| Shares Owned By Institutions | 0.04 % | |||
| Price To Earning | (2.93) X | |||
| Price To Book | 6.04 X | |||
| Price To Sales | 72.16 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in REMSleep Pink Sheet
REMSleep Holdings financial ratios help investors to determine whether REMSleep Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in REMSleep with respect to the benefits of owning REMSleep Holdings security.